{"id":"NCT01555164","sponsor":"Gilead Sciences","briefTitle":"A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone","officialTitle":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Ranolazine When Added to Metformin in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06","primaryCompletion":"2013-09","completion":"2013-10","firstPosted":"2012-03-15","resultsPosted":"2014-09-23","lastUpdate":"2014-09-23"},"enrollment":442,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Ranolazine","otherNames":["RanexaÂ®"]},{"type":"DRUG","name":"Placebo to match ranolazine","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Placebo to match metformin","otherNames":[]},{"type":"BEHAVIORAL","name":"Diet","otherNames":[]},{"type":"BEHAVIORAL","name":"Exercise","otherNames":[]}],"arms":[{"label":"Ranolazine+metformin","type":"EXPERIMENTAL"},{"label":"Placebo+metformin","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to determine the effect of ranolazine when added to metformin on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable metformin therapy in addition to diet and exercise.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24","timeFrame":"Baseline; Week 24","effectByArm":[{"arm":"Placebo+Metformin","deltaMin":7.86,"sd":1.003},{"arm":"Ranolazine+Metformin","deltaMin":7.72,"sd":1.069}],"pValues":[{"comp":"OG000 vs OG001","p":"0.306"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":13},"locations":{"siteCount":146,"countries":["United States","Canada","Czechia","Hungary","India","Israel","Mexico","Poland","Russia","South Africa","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":222},"commonTop":["Hyperglycaemia"]}}